Annual Grant Award Dollars

Investigator Title Sponsor ID Dates Amount
David Hooper, MD Genomics of Nephrotic Syndrome National Institutes of Health (NIH)/Duke University 265416 / A034556 7/27/21-5/31/25 $1,000
David Hooper, MD Preemptive Rituximab to Preven Department of Defense/Duke University N006814101 9/1/20-8/31/22 $2,859
Donna Claes, MD Development of the Pediatric P Food and Drug Administration/Children's Hospital of Philadelphia GRT-00000431 8/1/20-7/31/22 $7,999
David Hooper, MD VIRTUUS Children's Study-Valid National Institutes of Health (NIH)/Children's Hospital of Philadelphia 3200880522 6/1/21-5/31/22 $11,736
Mark M Mitsnefes, MD CKID IV (patient care only). National Institutes of Health (NIH)/Children's Mercy Hospital 18-0007 8/1/21-7/31/22 $16,895
Stuart Goldstein, MD Clinical Ancillary Study to th American Heart Association - National/Stanford University 62661882-212356 7/1/21-6/30/22 $26,400
Mark M Mitsnefes, MD Johns Hopkins CKID Strain Analysis National Institutes of Health (NIH)/Johns Hopkins University John Hopkins, Mitsne 6/1/21-7/31/21 $28,125
Elif Erkan, MD-MS CUREGN 2.0 - Midwest Pediatric Nephrology Consorti National Institutes of Health (NIH)/Nationwide Children's Hospital 700198-0620-00 6/1/21-5/31/22 $30,498
Mark M Mitsnefes, MD Purchased Services agreement b National Institutes of Health (NIH)/Children's Hospital of Philadelphia CHOP, Misnefes Mark 8/1/20-7/31/21 $31,250
David Hooper, MD Advancing Transplantation Outc National Institutes of Health (NIH)/Harvard Medical School GENFD0002098919 9/7/21-6/30/22 $41,892
Mark M Mitsnefes, MD CKID IV (patient care and sala National Institutes of Health (NIH)/Children's Mercy Hospital 18-0007 8/1/21-7/31/22 $42,430
Mark M Mitsnefes, MD Preserving Kidney Function in Patient-Centered Outcome Research Inst./Children's Hospital of Philadelphia GRT-00001109 6/1/21-5/31/22 $50,679
Mark M Mitsnefes, MD Phosphate binder therapy and chronic kidney diseas National Institutes of Health (NIH)/UCLA School of Public Health 1652 G YA029 5/1/21-4/30/22 $52,575
Stuart Goldstein, MD A multi-center, pilot study to University of Michigan 5500019918- Goldstei 9/1/20-8/31/22 $64,402
Ellen Cody, MD Systemic Lupus Erythematosus (SLE) Lupus Foundation of America LFA_Cody 10/1/21-9/30/22 $70,000
Elif Erkan, MD-MS Urinary Lipidomic profile in F National Institutes of Health (NIH) 1R03TR003916-01A1 8/1/21-5/31/22 $79,500
Meredith Schuh, MD KidneyCure Transition to Indep American Society of Nephrology ASN- Schuh 7/1/21-6/30/22 $100,000
Prasad Devarajan, MD Research Training in Pediatric Nephrology National Institutes of Health (NIH) T32DK007695 7/1/21-6/30/22 $120,492
Stuart Goldstein, MD Spread of Safety Interventions Agcy for Healthcare Research and Quality/Children's Hospital Boston RHS027401A 8/1/21-7/31/22 $137,190
Prasad Devarajan, MD Critical Translational Studies in Pediatric Nephrology National Institutes of Health (NIH) P50 DK096418 9/1/21-8/31/22 $850,000
Total Annual Grant Award Dollars $1,765,922

Annual Industry Award Dollars

Investigator Industry Sponsor Amount
Stuart Goldstein, MD Genentech, Inc. $589,313
David Hooper, MD Alnylam Parmaceuticals, Inc $40,011
David Hooper, MD Improving Renal Outcomes Collaborative $94,756
Stuart Goldstein, MD Otsuka America Pharmaceutical, Inc. $143,101
Meredith Schuh, MD Otsuka America Pharmaceutical, Inc. $105,096
Stuart Goldstein, MD Genentech, Inc. $460,384
Donna Claes, MD Bayer HealthCare Pharmaceuticals, Inc. $122,249
Total Annual Industry Award Dollars $1,554,910